IT1313553B1 - Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione. - Google Patents

Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.

Info

Publication number
IT1313553B1
IT1313553B1 IT1999MI001625A ITMI991625A IT1313553B1 IT 1313553 B1 IT1313553 B1 IT 1313553B1 IT 1999MI001625 A IT1999MI001625 A IT 1999MI001625A IT MI991625 A ITMI991625 A IT MI991625A IT 1313553 B1 IT1313553 B1 IT 1313553B1
Authority
IT
Italy
Prior art keywords
solutions
inhalation
optimized formulations
steroids
formulations constituted
Prior art date
Application number
IT1999MI001625A
Other languages
English (en)
Inventor
Chiara Malvolti
Raffaella Garzia
Gaetano Brambilla
Paolo Chiesi
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of ITMI991625A0 publication Critical patent/ITMI991625A0/it
Priority to IT1999MI001625A priority Critical patent/IT1313553B1/it
Priority to DK00956216T priority patent/DK1198224T3/da
Priority to DE60003183T priority patent/DE60003183T2/de
Priority to CZ20020257A priority patent/CZ299071B6/cs
Priority to PL353470A priority patent/PL198817B1/pl
Priority to EP00956216A priority patent/EP1198224B1/en
Priority to PT00956216T priority patent/PT1198224E/pt
Priority to ES00956216T priority patent/ES2200913T3/es
Priority to US10/030,101 priority patent/US6967017B1/en
Priority to PCT/EP2000/006916 priority patent/WO2001007014A1/en
Priority to AU68250/00A priority patent/AU6825000A/en
Priority to HU0201956A priority patent/HUP0201956A3/hu
Priority to SI200030152T priority patent/SI1198224T1/xx
Priority to AT00956216T priority patent/ATE241959T1/de
Publication of ITMI991625A1 publication Critical patent/ITMI991625A1/it
Priority to NO20020342A priority patent/NO20020342L/no
Application granted granted Critical
Publication of IT1313553B1 publication Critical patent/IT1313553B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
IT1999MI001625A 1999-07-23 1999-07-23 Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione. IT1313553B1 (it)

Priority Applications (15)

Application Number Priority Date Filing Date Title
IT1999MI001625A IT1313553B1 (it) 1999-07-23 1999-07-23 Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
US10/030,101 US6967017B1 (en) 1999-07-23 2000-07-20 Formulations of steroid solutions for inhalatory administration
AU68250/00A AU6825000A (en) 1999-07-23 2000-07-20 Formulations of steroid solutions for inhalatory administration
CZ20020257A CZ299071B6 (cs) 1999-07-23 2000-07-20 Stálý farmaceutický steroidní prostredek pro inhalaci
PL353470A PL198817B1 (pl) 1999-07-23 2000-07-20 Preparaty roztworów steroidów do podawania wziewnego i sposób wytwarzania i sposób wytwarzania tych preparatów
EP00956216A EP1198224B1 (en) 1999-07-23 2000-07-20 Formulations of steroid solutions for inhalatory administration
PT00956216T PT1198224E (pt) 1999-07-23 2000-07-20 Formulacoes de solucoes de esteroides para administracao por inalacao
ES00956216T ES2200913T3 (es) 1999-07-23 2000-07-20 Formulaciones de soluciones esteroides para administracion por inhalacion.
DK00956216T DK1198224T3 (da) 1999-07-23 2000-07-20 Formuleringer til opløsninger af steroider til indgivelse via inhalering
PCT/EP2000/006916 WO2001007014A1 (en) 1999-07-23 2000-07-20 Formulations of steroid solutions for inhalatory administration
DE60003183T DE60003183T2 (de) 1999-07-23 2000-07-20 Formulierungen von steroidlösungen zur inhalativen verabreichung
HU0201956A HUP0201956A3 (en) 1999-07-23 2000-07-20 Formulations of steroid solutions for inhalatory administration and process for their preparation
SI200030152T SI1198224T1 (en) 1999-07-23 2000-07-20 Formulations of steroid solutions for inhalatory administration
AT00956216T ATE241959T1 (de) 1999-07-23 2000-07-20 Formulierungen von steroidlösungen zur inhalativen verabreichung
NO20020342A NO20020342L (no) 1999-07-23 2002-01-22 Formuleringer av steroidlösninger for inhalasjonsadministrasjon

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999MI001625A IT1313553B1 (it) 1999-07-23 1999-07-23 Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.

Publications (3)

Publication Number Publication Date
ITMI991625A0 ITMI991625A0 (it) 1999-07-23
ITMI991625A1 ITMI991625A1 (it) 2001-01-23
IT1313553B1 true IT1313553B1 (it) 2002-09-09

Family

ID=11383393

Family Applications (1)

Application Number Title Priority Date Filing Date
IT1999MI001625A IT1313553B1 (it) 1999-07-23 1999-07-23 Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.

Country Status (14)

Country Link
US (1) US6967017B1 (it)
EP (1) EP1198224B1 (it)
AT (1) ATE241959T1 (it)
AU (1) AU6825000A (it)
CZ (1) CZ299071B6 (it)
DE (1) DE60003183T2 (it)
DK (1) DK1198224T3 (it)
ES (1) ES2200913T3 (it)
HU (1) HUP0201956A3 (it)
IT (1) IT1313553B1 (it)
NO (1) NO20020342L (it)
PL (1) PL198817B1 (it)
PT (1) PT1198224E (it)
WO (1) WO2001007014A1 (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20010614A1 (it) * 2001-10-16 2003-04-16 Italchimici S P A Preparazione farmaceutica di una soluzione idro/propilenica di budesonide e suo procedimento di preparazione.
US20040265238A1 (en) * 2003-06-27 2004-12-30 Imtiaz Chaudry Inhalable formulations for treating pulmonary hypertension and methods of using same
ITMI20032054A1 (it) 2003-10-22 2005-04-23 Monteres S R L Processo per la preparazione di sospensioni farmaceutiche da inalare.
AR041873A1 (es) * 2003-10-30 2005-06-01 Pablo Cassara Srl Lab Una formulacion farmaceutica en aerosol adecuada para la inhalacion oral o nasal que contienen glucocorticoides en solucion estable al almacenamiento; un metodo para estabilzar formulaciones y uso de un agente estabilizante
PE20050941A1 (es) * 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
ITRM20040268A1 (it) * 2004-05-31 2004-08-31 Italchimici S P A Formulazione farmaceutica di una soluzione stabile di formoterolo per via inalatoria e suo precedimento di preparazione.
GEP20105040B (en) * 2005-02-25 2010-07-12 Chiesi Farm Spa Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent
GB0604141D0 (en) * 2006-03-01 2006-04-12 Arrow Int Ltd Nebulizer formulation
CZ302596B6 (cs) * 2007-04-12 2011-07-27 Jihoceská univerzita v Ceských Budejovicích, Zemedelská fakulta Zpusob zpracování biomasy jetele lucního

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3361306A (en) 1966-03-31 1968-01-02 Merck & Co Inc Aerosol unit dispensing uniform amounts of a medically active ingredient
US3622053A (en) 1969-12-10 1971-11-23 Schering Corp Aerosol inhaler with flip-up nozzle
MX3864E (es) * 1975-05-27 1981-08-26 Syntex Corp Un proceso para prepara el compuesto cristalino 6-fluiro-11b 21-dihiroxi-16 17-isopropilidendioxipregna-1 4-dien-3 20-diona
US4185100A (en) 1976-05-13 1980-01-22 Johnson & Johnson Topical anti-inflammatory drug therapy
US4499108A (en) 1983-06-08 1985-02-12 Schering Corporation Stable pleasant-tasting albuterol sulfate pharmaceutical formulations
IT1196142B (it) 1984-06-11 1988-11-10 Sicor Spa Procedimento per la preparazione di 16,17-acetali di derivati pregnanici e nuovi composti ottenuti
US5192528A (en) 1985-05-22 1993-03-09 Liposome Technology, Inc. Corticosteroid inhalation treatment method
GB8828477D0 (en) 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
US5225183A (en) 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
IL97065A (en) 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
EP0563048A1 (en) 1990-12-19 1993-10-06 Smithkline Beecham Corporation Aerosol formulations
US6006745A (en) 1990-12-21 1999-12-28 Minnesota Mining And Manufacturing Company Device for delivering an aerosol
EP0504112A3 (en) 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
WO1992020391A1 (en) 1991-05-21 1992-11-26 Abbott Laboratories Aerosol inhalation device
EP0601036B1 (de) 1991-08-29 1999-04-28 Broncho-Air Medizintechnik AG Medizinisches gerät zur inhalation von dosier-aerosolen
NZ244439A (en) 1991-09-25 1994-01-26 Fisons Plc Pressurised aerosol compositions comprising hydrofluoroalkane, dispersed
IL104068A (en) 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
NZ246421A (en) 1991-12-18 1996-05-28 Minnesota Mining & Mfg Aerosol formulation containing a drug and a propellant and which is substantially free of surfactant
DE4230876A1 (de) 1992-03-17 1993-09-23 Asta Medica Ag Druckgaspackungen unter verwendung von polyoxyethylen-glyceryl-oleaten
AU6048694A (en) 1992-12-09 1994-07-04 Paul D. Jager Stabilized medicinal aerosol solution formulations
SE9203743D0 (sv) 1992-12-11 1992-12-11 Astra Ab Efficient use
AU4066693A (en) 1992-12-23 1994-07-19 Bernhard Hugemann Compacted drug body for use in the mechanical generation of inhalable active-substance particles
ES2122261T3 (es) 1993-03-17 1998-12-16 Minnesota Mining & Mfg Formulacion de aerosol que contiene un adyuvante de dispersion derivado de un ester, una amida o un mercaptoester.
WO1994021228A1 (en) 1993-03-17 1994-09-29 Minnesota Mining And Manufacturing Company Aerosol formulation containing a diol-diacid derived dispersing aid
US6596260B1 (en) 1993-08-27 2003-07-22 Novartis Corporation Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol
EP0735884B1 (en) 1993-12-20 2000-04-26 Minnesota Mining And Manufacturing Company Flunisolide aerosol formulations
GB9425160D0 (en) 1994-12-10 1995-02-08 Glaxo Group Ltd Medicaments
CN1088580C (zh) 1994-12-22 2002-08-07 阿斯特拉公司 气溶胶药物制剂
GB9426252D0 (en) 1994-12-24 1995-02-22 Glaxo Group Ltd Pharmaceutical composition
DE4446891A1 (de) 1994-12-27 1996-07-04 Falk Pharma Gmbh Stabile wäßrige Budesonid-Lösung
US5653961A (en) 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
GEP20002266B (en) 1995-04-14 2000-10-25 Glaxo Wellcome Inc Metered Dose Inhaler, the Inhaler System Comprising the Same and Method for Treatment of Respiratory Disturbances
EP1166811B1 (en) 1995-04-14 2006-12-06 SmithKline Beecham Corporation Metered dose inhaler for fluticasone propionate
WO1996032150A1 (en) 1995-04-14 1996-10-17 Glaxo Wellcome Inc. Metered dose inhaler for salmeterol
DK0820279T3 (da) 1995-04-14 2002-10-07 Smithkline Beecham Corp Dosisudmålende inhalator til Albuterol
GB9612297D0 (en) 1996-06-11 1996-08-14 Minnesota Mining & Mfg Medicinal aerosol formulations
EP0914143A1 (en) 1996-07-08 1999-05-12 Rhone-Poulenc Rorer Limited Medicinal cyclosporin-a aerosol solution formulation
WO1998003533A1 (en) 1996-07-24 1998-01-29 Oligos Etc. And Oligos Therapeutics, Inc. Antisense oligonucleotides as antibacterial agents
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
GB9620187D0 (en) 1996-09-27 1996-11-13 Minnesota Mining & Mfg Medicinal aerosol formulations
AU726510B2 (en) 1996-12-04 2000-11-09 Consort Medical Plc Pharmaceutical compositions and devices for their administration
US6413496B1 (en) 1996-12-04 2002-07-02 Biogland Ireland (R&D) Limited Pharmaceutical compositions and devices for their administration
DK1014943T3 (da) 1997-02-05 2002-10-14 Jago Res Ag Medicinske aerosolformuleringer
US6126919A (en) 1997-02-07 2000-10-03 3M Innovative Properties Company Biocompatible compounds for pharmaceutical drug delivery systems
US5891419A (en) 1997-04-21 1999-04-06 Aeropharm Technology Limited Environmentally safe flunisolide aerosol formulations for oral inhalation
GB2326334A (en) 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
BR7702049U (pt) 1997-09-05 1999-09-14 Chiesi Farma Spa Bico pulverizador para utilização em inalador oral para medicamentos aerossóis
US5954047A (en) 1997-10-17 1999-09-21 Systemic Pulmonary Development, Ltd. Methods and apparatus for delivering aerosolized medication
US6045784A (en) 1998-05-07 2000-04-04 The Procter & Gamble Company Aerosol package compositions containing fluorinated hydrocarbon propellants
SE9802073D0 (sv) 1998-06-11 1998-06-11 Astra Ab New use
AU759222B2 (en) 1998-06-18 2003-04-10 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceutical formulations for aerosols with two or more active substances
US6451285B2 (en) 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
US6241969B1 (en) * 1998-06-26 2001-06-05 Elan Corporation Plc Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
NZ509328A (en) 1998-07-24 2002-11-26 Jago Res A Medicinal aerosol formulations
ES2193726T3 (es) 1998-08-04 2003-11-01 Jago Res Ag Formulaciones de aerosol medicinales.
DE19847969A1 (de) 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Lagerfähig flüssige Formulierung mit Formoterol
BR9914507A (pt) 1998-10-17 2001-06-26 Boehringer Ingelheim Pharma Concentrado de substância ativa com formoterol, adequado para armazenagem
DK1283036T3 (da) 1998-11-13 2008-03-25 Jagotec Ag Törpulver til inhalation
IT1303788B1 (it) 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
US6290930B1 (en) 1998-12-18 2001-09-18 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
SK286981B6 (sk) 1999-03-05 2009-08-06 Chiesi Farmaceutici S.P.A. Prášok na použitie v inhalátore na suché prášky, nosič na tento prášok a spôsob výroby prášku
US6315985B1 (en) 1999-06-18 2001-11-13 3M Innovative Properties Company C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
DE60019167T2 (de) 1999-12-24 2006-05-11 Glaxo Group Ltd., Greenford Pharmazeutische aerosol formulierung enthaltend salmeterol und fluticason
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
IT1318514B1 (it) 2000-05-12 2003-08-27 Chiesi Farma Spa Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
ME00220B (me) 2000-05-22 2010-10-10 Chiesi Farm Spa Stabilne farmaceutske formulacije rastvora za inhalatore odmjerene doze pod pritiskom

Also Published As

Publication number Publication date
DE60003183T2 (de) 2004-04-29
ITMI991625A1 (it) 2001-01-23
CZ299071B6 (cs) 2008-04-16
WO2001007014A1 (en) 2001-02-01
EP1198224B1 (en) 2003-06-04
ES2200913T3 (es) 2004-03-16
DE60003183D1 (de) 2003-07-10
PL198817B1 (pl) 2008-07-31
NO20020342D0 (no) 2002-01-22
US6967017B1 (en) 2005-11-22
HUP0201956A3 (en) 2003-10-28
ITMI991625A0 (it) 1999-07-23
CZ2002257A3 (cs) 2002-05-15
PL353470A1 (en) 2003-11-17
EP1198224A1 (en) 2002-04-24
AU6825000A (en) 2001-02-13
ATE241959T1 (de) 2003-06-15
HUP0201956A2 (en) 2002-10-28
DK1198224T3 (da) 2003-09-29
NO20020342L (no) 2002-01-22
PT1198224E (pt) 2003-10-31

Similar Documents

Publication Publication Date Title
BR9915095A (pt) Composição farmacêutica ministrável em aerosol
WO2005037246A3 (de) Wässrige aerosol-zubereitung
WO2002083079A3 (en) Aerosol compositions containing formoterol for delivery to the lungs via nebulization
ATE322249T1 (de) System zur abgabe einer tobramycin-formulierung
WO2005065185A3 (en) Temperature-stable formulations, and methods of development thereof
MA27702A1 (fr) Preparation de suspensions aqueuses steriles comprenant des ingredients actifs cristallins micronises, destinees a l'inhalation
DE60120648D1 (de) Formulierungen von copolymer 1 (glatirameracetat) zur oralen, nasalen und pulmonalen verabreichung
HRP20030046B1 (en) Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome
WO2008013929A3 (en) Anti-migraine oral spray formulations and methods
WO2005044226A3 (en) Lipid formulations for spontaneous drug encapsulation
IT1313553B1 (it) Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
NO20023875L (no) Stabilt nasalt, oralt eller sublingualt anvendbart preparat
WO2003079993A3 (en) hGH (HUMAN GROWTH HORMONE) FORMULATIONS FOR PULMONARY ADMINISTRATION
WO2001047913A3 (de) Substituierte n-benzyl-indol-3-yl- glyoxylsäure-derivate antitumorwirkung
DK1280558T3 (da) Halvfast indgivelsesvehikel og farmaceutiske sammensætninger
ATE350024T1 (de) Flüssige zubereitung enthaltend tobramycin
ATE311928T1 (de) (-)-pseudoephedrin als sympathomimetisches arzneimittel
AU2003278962C1 (en) Nasal compositions comprising a mucopolysaccharide and propylene glycol
SE9900177L (sv) Användning av en beredning innehållande myrsyra för framställning av ett läkemedel för behandling av vårtor, orsakade av Papillomavirus
WO2004033484A3 (en) Use of stable glutamine derivatives to improve drug absorption
AU2001258859A1 (en) Pralmorelin-containing nasal drop preparations
CN105520944A (zh) 一种稳定的吸入用茶碱乙酸氨溴索溶液
DE50202865D1 (de) Herstellung reiner stereoisomere von tricyclo-[5.2.1.0(2.6) ]-dec-9-yl-xanthogenat sowie deren verwendung als arzneimittel
EA200300430A1 (ru) Новые фармацевтические композиции, содержащие эпинастин и псевдоэфедрин
BR0205625A (pt) Formulações nasais